Skip to main content
. 2022 Dec 27;24(1):411. doi: 10.3390/ijms24010411

Figure 6.

Figure 6

Brn3A+ RGCs in diabetic mice. (A) Representative images of immunostaining by using anti-Brn3A antibody in retinal whole-mount preparations of control and AION eyes of diabetic mice treated with 20 and 0 mg/kg PGZ 3 weeks after AION (magnification: 200×). (B) Bar graph showing average Brn3A+ cell counts in all 4 conditions 3 weeks after AION (* p < 0.05).